Memorial Sloan Kettering Cancer Center MSK 2 — New York, New York

Memorial Sloan Kettering Cancer Center MSK 2 is a clinical research site located in New York, New York, United States 10021.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

Memorial Sloan Kettering Cancer Center MSK 2 has participated in 1 clinical trials.

Therapeutic areas: Diffuse Large B-Cell Lymphoma.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Memorial Sloan Kettering Cancer Center MSK 2?

Memorial Sloan Kettering Cancer Center MSK 2 has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Memorial Sloan Kettering Cancer Center MSK 2 conducted?

Memorial Sloan Kettering Cancer Center MSK 2 has 1 clinical trials on record. Their work covers Diffuse Large B-Cell Lymphoma.

Is Memorial Sloan Kettering Cancer Center MSK 2 accredited by Crixeo Health?

Memorial Sloan Kettering Cancer Center MSK 2 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Memorial Sloan Kettering Cancer Center MSK 2?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.